The UK has seen a surge in the number of type 2 diabetes cases, with data analysis from Diabetes UK showing that one in five ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Every time I get on my phone, there are a ton of ads on how to cure Type 2 diabetes. Are any of them worth looking at? — F.N. ANSWER: If the ads are for comprehensive diet and exercise programs with ...

Dear M.W.: Stevia is a natural extract of the Stevia rebaudiana plant. The raw leaves are not considered safe, but purified ...

Despite heavy demand for its weight-loss and diabetes treatments, limited supply hobbled Eli Lilly's fourth-quarter sales.

There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.

Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular ...

Lilly's fourth-quarter profit doubles, driven by diabetes and obesity treatments. Strong revenue and forecast for 2025.